Tag:
Geodon
Latest Headlines
Latest Headlines
Pfizer cancels trial of Geodon in bipolar kids
Pfizer's halt to its arthritis drug trial has captured most of the headlines today, but the company has also pulled out of another important study: Its test of the antipsychotic drug Geodon in
Will Geodon trial mistakes cost Pfizer pediatric exclusivity?
Dosing snafus during a pediatric trial of Geodon may end up costing Pfizer ( NYSE: PFE ) that coveted six extra months of U.S. exclusivity, consultants tell the Financial Times. And that loss would cut
FDA warns Pfizer on overdosed children in Geodon study
The FDA has warned Pfizer to keep closer tabs on its clinical trials. At issue: a pediatric trial of its antipsychotic drug Geodon. According to the agency, at least 13 children in the trial received
M.D. pilot made off-label Pfizer rounds
A penchant for helicopters characterizes forensic psychiatrist Neil Kaye, M.D., a prominent player in the recent $2.3 billion Pfizer off-label marketing settlement . According to Bnet, high-roller
